Announcement on Progress in the Proposed Transfer of Holding Subsidiary Equity
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
Shandong Buchang Pharmaceuticals Co., Ltd. has announced progress regarding the proposed transfer of equity in its holding subsidiary, Hunan Zhongce Biotechnology Co., Ltd. The company has completed the necessary registration changes and obtained a new business license following the transfer. Investors are cautioned about potential market, management, and operational risks following this transaction.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Progress in the Proposed Transfer of Holding Subsidiary Equity
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix
Follow Shandong Buchang Pharmaceuticals into a list and get an email when it puts out news.
Follow Shandong Buchang Pharmaceuticals